To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease
Status:
Withdrawn
Trial end date:
2018-12-03
Target enrollment:
Participant gender:
Summary
ASTUTE is a pragmatic open randomised 12-week multinational trial to evaluate the
effectiveness of aclidinium bromide/formoterol fumarate dihydrate fixed-dose combination
compared to standard of care bronchodilators in chronic obstructive pulmonary disease.